C-Met, also known as hepatocyte growth factor receptor (HGFR), is a receptor tyrosine kinase that activates the RAS/MAPK and PI3K/Akt signaling pathways and mediates tumor cell proliferation, angiogenesis, migration, and metastasis (Breen et al., 2020). This evidence concerns the gene MET and neoplasm.